Due to the patient high throughput in our vaccination center, we do not have prevaccination
BP values. However, 8 of 9 patients reported otherwise well controlled hypertension. Our …

Overall, we identified a total of 912 individuals who received≥ 3 mRNA vaccine doses and
were subsequently diagnosed with COVID-19 during the Omicron surge, of whom 145 …

Coronavirus disease 2019 (COVID-19) vaccines proved a strong clinical efficacy against
symptomatic or moderate/severe COVID-19 and are considered the most promising …

Several types of vaccines have been developed to prevent the coronavirus disease 2019
(COVID-19). It is important to understand whether demographic and clinical variables affect …

To fight the COVID-19 pandemic, messenger RNA (mRNA) vaccines were the first to be
adopted by vaccination programs worldwide. We sought to investigate the short-term effect …

The benefits of SARS-CoV-2 spike mRNA vaccines are well known, including a significant
decline in COVID-19 morbidity and a decrease in the mortality rate of SARS-CoV-2 infected …

To the editor: We read with great interest the report of Negrea and Rovin of 2 cases of IgA
nephropathy with gross hematuria following the Moderna vaccine for severe acute …

To the editor: Although the pathogenesis of minimal change disease (MCD) has not yet
been clearly elucidated, immune dysregulation is probable, 1 and the risk of relapse after …

We would like to report a similar observation. A 22-year-old adult male patient has been
followed up in our department since 2019 for an idiopathic nephrotic syndrome due to …

Background Literature data suggests that age, gender and body mass index (BMI) could be
associated with difference in immune responses to vaccines. The first goal of the study was …